Related Experiment Video
Updated: Mar 27, 2026
08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
12.4K
Noteworthy Articles in 2015 for the Cardiothoracic Anesthesiologist
Dirk J Varelmann1, J Daniel Muehlschlegel2
1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA dvarelmann@partners.org.
Seminars in Cardiothoracic and Vascular Anesthesia
|January 20, 2016
Summary
In 2015, major trials in cardiothoracic anesthesia advanced understanding of echocardiography, pharmacology, and genetics. Key studies explored atrial fibrillation ablation and remote ischemic preconditioning to improve patient outcomes.
Area of Science:
- Cardiothoracic Anesthesia
- Applied Physiology
- Pharmacology
Background:
- Cardiac anesthesiologists are experts in physiology, physics, ultrasonography, and pharmacology.
- Significant advancements in 2015 expanded knowledge in echocardiography, pharmacology, molecular biology, and genetics.
Purpose of the Study:
- To evaluate the impact of large multicenter, randomized controlled trials published in 2015 on cardiothoracic anesthesia.
- To address key clinical questions regarding surgical atrial fibrillation ablation and remote ischemic preconditioning.
Main Methods:
- Review of large multicenter, randomized controlled trials.
- Focus on outcome studies relevant to cardiac anesthesiologists.
Main Results:
- Selected studies contributed to knowledge in echocardiography, pharmacology, molecular biology, and genetics.
- Investigated the efficacy of atrial fibrillation ablation during mitral valve surgery.
- Assessed the effectiveness of remote ischemic preconditioning in reducing postoperative events.
Conclusions:
- The year 2015 marked significant progress in understanding myocardial injury mechanisms.
- Evidence-based medicine was advanced to improve patient outcomes in cardiothoracic anesthesia.
